References
- Doyle LW, Cheong JL, Ehrenkranz RA, et al. Late (>7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochr Database Syst Rev. 2017;10:CD001145.
- Dassios T, Kaltsogianni O, Hickey A, et al. Chronology and determinants of respiratory function changes following administration of systematic postnatal corticosteroids in extremely preterm infants. J Pediatr. 2019;215:17–23.
- Jobe AH. Postnatal corticosteroids for bronchopulmonary dysplasia. Clin Perinatol. 2009;36(1):177–188.
- Kamlin CO, Davis PG, Morley CJ. Predicting successful extubation of very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2005;91(3):F180–183.
- Wright CM, Booth IW, Buckler JM, et al. Growth reference charts for use in the United Kingdom. Arch Dis Child. 2002;86(1):11–14.
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723–1729.
- Dassios T, Curley A, Morley C, et al. Using measurements of shunt and ventilation-to-perfusion ratio to quantify the severity of bronchopulmonary dysplasia. Neonatology. 2015;107(4):283–288.
- Dassios T, Ali K, Rossor T, et al. Ventilation/perfusion ratio and right to left shunt in healthy newborn infants. J Clin Monit Comput. 2017;31(6):1229–1234.
- Doyle LW, Davis PG, Morley CJ, et al. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics. 2006;117(1):75–83.
- Zeng L, Tian J, Song F, et al. Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2018;103(6):F506–F511.